152 related articles for article (PubMed ID: 8694896)
1. Effects of continuous glucocorticoid infusion on bone metabolism in the rat.
King CS; Weir EC; Gundberg CW; Fox J; Insogna KL
Calcif Tissue Int; 1996 Sep; 59(3):184-91. PubMed ID: 8694896
[TBL] [Abstract][Full Text] [Related]
2. Dosing-time dependent effect of dexamethasone on bone density in rats.
Takahashi M; Ushijima K; Hayashi Y; Maekawa T; Ando H; Tsuruoka S; Fujimura A
Life Sci; 2010 Jan; 86(1-2):24-9. PubMed ID: 19903488
[TBL] [Abstract][Full Text] [Related]
3. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
4. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
[TBL] [Abstract][Full Text] [Related]
5. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
6. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
Iida-Klein A; Lu SS; Kapadia R; Burkhart M; Moreno A; Dempster DW; Lindsay R
J Endocrinol; 2005 Sep; 186(3):549-57. PubMed ID: 16135674
[TBL] [Abstract][Full Text] [Related]
7. Parathyroidectomy does not prevent bone loss in the oophorectomized rat.
Sims NA; Morris HA; Moore RJ; Durbridge TC
J Bone Miner Res; 1994 Dec; 9(12):1859-63. PubMed ID: 7872050
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone.
Marenzana M; Greenslade K; Eddleston A; Okoye R; Marshall D; Moore A; Robinson MK
Arthritis Rheum; 2011 Aug; 63(8):2385-95. PubMed ID: 21484764
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
11. Effect of duration of alcohol consumption on calcium and bone metabolism during pregnancy in the rat.
Keiver K; Weinberg J
Alcohol Clin Exp Res; 2003 Sep; 27(9):1507-19. PubMed ID: 14506413
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
[TBL] [Abstract][Full Text] [Related]
13. Effect of taurine feeding on bone mineral density and bone markers in rats.
Choi MJ; Seo JN
Adv Exp Med Biol; 2013; 776():51-8. PubMed ID: 23392870
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
15. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
Joffe I; Katz I; Sehgal S; Bex F; Kharode Y; Tamasi J; Epstein S
Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
[TBL] [Abstract][Full Text] [Related]
16. Elevated intact parathyroid hormone is associated with reduced biochemical markers of bone formation and resorption measured in blood in infant piglets receiving oral dexamethasone for 15 days.
Guo CY; Weiler H; Atkinson SA
Biol Neonate; 2001; 80(4):295-9. PubMed ID: 11641553
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
18. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
19. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
[TBL] [Abstract][Full Text] [Related]
20. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
